30
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Participants’ perceptions support the coexistence of benefits and burdens of cancer clinical trial participation

, PhD, RN, CPNP-ACORCID Icon, , PhD, FAANORCID Icon, , PhDORCID Icon, , PhD, RNORCID Icon & , PhD, RN, FAANORCID Icon
Published online: 22 Jun 2024
 

Abstract

Background

To advance oncology treatment for adults, comprehensive understanding of how and why people decide to enroll in, remain in, and withdraw from cancer clinical trials is needed. While quantitative findings provide insights into these benefits and burdens, they provide limited understanding of how adults with cancer appraise their situation and approach decisions to undertake a clinical trial. The goal of this mixed methods analysis was to conceptualize participants’ assessment of benefits and burdens related to cancer clinical trial participation.

Materials and methods

This sub-group analysis of 21 participants was part of a larger sequential, explanatory mixed methods study. We used Creamer’s integrated approach to linking quantitative and qualitative data to assess convergence, with qualitative data explaining quantitative results. Participants were grouped into four categories based on quantitative benefit/burden scores and thematic analysis of their qualitative data was used to describe these categories.

Results

Across groups participants varied in descriptions of benefits and burdens of cancer clinical trial participation and reasons for participating. Those reporting high benefit/low burden described “seizing the opportunity to participate;” those reporting low benefit/low burden described “taking responsibility” through trial participation; those reporting low benefit/high burden described how they were “willing to endure,” and those with high benefit/high burden emphasized “deciding to act.”

Conclusions

Participants’ qualitative descriptions of benefits and burdens were more nuanced and dynamic than reflected in their quantitative ratings. Thus, current measures may be missing important concepts, such as logistic challenges of trial participation. Our results have implications for consenting procedures and decisional support guidance offered to patients and their caregivers.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by The National Institutes of Health/National Cancer Institute under Grant R01CA196131 (PI: Ulrich).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 446.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.